Patent · US Active

Crystalline form F of imatinib mesylate

US8633213B2 · kind B2 · utility

0Cited by
1References
2Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 15, 2012
Grant dateJan 21, 2014
Priority date—
Expiry dateMay 15, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Crystalline forms of imatinib mesylate (F, G, H, I and K) and their respective characterization are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.